Basic Information
RNALocate ID: | RLID:11001680 |
RNA Symbol: | hsa-miR-23b-3p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-23b |
RNA ID: | miRBase:MIMAT0000418 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23539611 |
Tissue/Cell Line: | Seminal plasma |
Method: | Microarray |
Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001725 | Cytoplasm | Cell line (HeLa) | 21695135 |
RLID:01001726 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001727 | Mitochondrion | Myotube | 27396686 |
RLID:01001728 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001729 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001730 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001731 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001732 | Nucleus | Colon adenocarcinoma cells | 20864815 |
RLID:11001669 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
RLID:11001670 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11001671 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001672 | Exosome | Renal cancer cells | 21670082 |
RLID:11001673 | Exosome | Ovarian follicular fluid | 22116803 |
RLID:11001674 | Exosome | Breast milk | 22211110 |
RLID:11001675 | Exosome | Brain tissue | 23382797 |
RLID:11001676 | Exosome | Plasma | 23663360 |
RLID:11001677 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001678 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11001679 | Microvesicle | Plasma | 23077538 |
RLID-D:11000071 | Exosome | Endothelial cells|Epithelial cells|Seminal fluid|Tongue tissue | |
RLID-D:11000346 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-23b-3p | Diffuse large b cell lymphoma | MNDR-E-MI-32119 |
MNDR | hsa-miR-23b-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-32120 |
MNDR | hsa-miR-23b-3p | Oral squamous cell carcinoma | MNDR-E-MI-32121 |
MNDR | hsa-miR-23b-3p | Medulloblastoma | MNDR-E-MI-32122 |
MNDR | hsa-miR-23b-3p | B cell lymphoma of malt type | MNDR-E-MI-32123 |
MNDR | hsa-miR-23b-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-32124 |
MNDR | hsa-miR-23b-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-32125 |
MNDR | hsa-miR-23b-3p | Lymphoma | MNDR-E-MI-32126 |
MNDR | hsa-miR-23b-3p | Non-hodgkin lymphoma | MNDR-E-MI-32127 |
MNDR | hsa-miR-23b-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-32128 |
MNDR | hsa-miR-23b-3p | Dermatomyositis | MNDR-E-MI-32129 |
MNDR | hsa-miR-23b-3p | Prostate cancer | MNDR-E-MI-32130 |
MNDR | hsa-miR-23b-3p | Gastric cancer | MNDR-E-MI-32131 |
MNDR | hsa-miR-23b-3p | Gastric lymphoma | MNDR-E-MI-32132 |
MNDR | hsa-miR-23b-3p | Alzheimer disease | MNDR-E-MI-32133 |
MNDR | hsa-miR-23b-3p | Intracranial aneurysm | MNDR-E-MI-32134 |
MNDR | hsa-miR-23b-3p | Bladder cancer | MNDR-E-MI-32135 |
MNDR | hsa-miR-23b-3p | Esophageal carcinoma | MNDR-E-MI-32136 |
MNDR | hsa-miR-23b-3p | Dysautonomia familial | MNDR-E-MI-32137 |
MNDR | hsa-miR-23b-3p | Myotonic dystrophy | MNDR-E-MI-32138 |
MNDR | hsa-miR-23b-3p | Seizures | MNDR-E-MI-32139 |
MNDR | hsa-miR-23b-3p | Huntington disease | MNDR-E-MI-32140 |
MNDR | hsa-miR-23b-3p | Cardiovascular disease | MNDR-E-MI-32141 |
MNDR | hsa-miR-23b-3p | Carotid stenosis | MNDR-E-MI-32142 |
MNDR | hsa-miR-23b-3p | Brain cancer | MNDR-E-MI-32143 |
MNDR | hsa-miR-23b-3p | Uterine fibroid | MNDR-E-MI-32144 |
MNDR | hsa-miR-23b-3p | Lung cancer | MNDR-E-MI-32145 |
MNDR | hsa-miR-23b-3p | Down syndrome | MNDR-E-MI-32146 |
MNDR | hsa-miR-23b-3p | Parkinson disease | MNDR-E-MI-32147 |
MNDR | hsa-miR-23b-3p | Breast cancer | MNDR-E-MI-32148 |
MNDR | hsa-miR-23b-3p | Thyroid cancer | MNDR-E-MI-32149 |
MNDR | hsa-miR-23b-3p | Pituitary neoplasms | MNDR-E-MI-32150 |
MNDR | hsa-miR-23b-3p | Pancreatic cancer | MNDR-E-MI-32151 |
MNDR | hsa-miR-23b-3p | Melanoma | MNDR-E-MI-32152 |
MNDR | hsa-miR-23b-3p | Nephroblastoma | MNDR-E-MI-32153 |
MNDR | hsa-miR-23b-3p | Colon cancer | MNDR-E-MI-32154 |
MNDR | hsa-miR-23b-3p | Ischemic attack transient | MNDR-E-MI-32155 |
MNDR | hsa-miR-23b-3p | Colon adenocarcinoma | MNDR-E-MI-32156 |
MNDR | hsa-miR-23b-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-32157 |
MNDR | hsa-miR-23b-3p | Familial ovarian cancer | MNDR-E-MI-32158 |
MNDR | hsa-miR-23b-3p | Prostate adenocarcinoma | MNDR-E-MI-32159 |
MNDR | hsa-miR-23b-3p | Renal cancer | MNDR-E-MI-32160 |
MNDR | hsa-miR-23b-3p | Carcinoma ductal breast | MNDR-E-MI-32161 |
MNDR | hsa-miR-23b-3p | Glioblastoma | MNDR-E-MI-32162 |
MNDR | hsa-miR-23b-3p | Glioma | MNDR-E-MI-32163 |
MNDR | hsa-miR-23b-3p | Chordoma | MNDR-E-MI-32164 |
MNDR | hsa-miR-23b-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-32165 |
MNDR | hsa-miR-23b-3p | Temporal lobe epilepsy | MNDR-E-MI-32166 |
MNDR | hsa-miR-23b-3p | Osteosarcoma | MNDR-E-MI-32167 |
MNDR | hsa-miR-23b-3p | Liposarcoma | MNDR-E-MI-32168 |
MNDR | hsa-miR-23b-3p | Inclusion body myositis | MNDR-E-MI-32169 |
MNDR | hsa-miR-23b-3p | Meningioma | MNDR-E-MI-32170 |
MNDR | hsa-miR-23b-3p | Liver cancer | MNDR-E-MI-32171 |
MNDR | hsa-miR-23b-3p | Uterine cancer | MNDR-E-MI-32172 |
MNDR | hsa-miR-23b-3p | Cervical adenocarcinoma | MNDR-E-MI-32173 |
MNDR | hsa-miR-23b-3p | Gastric adenocarcinoma | MNDR-E-MI-32174 |
MNDR | hsa-miR-23b-3p | Cervical squamous cell carcinoma | MNDR-E-MI-32175 |
MNDR | hsa-miR-23b-3p | Pituitary adenoma | MNDR-E-MI-32176 |
MNDR | hsa-miR-23b-3p | Lung squamous cell carcinoma | MNDR-E-MI-32177 |
MNDR | hsa-miR-23b-3p | Carcinoma lung non-small-cell | MNDR-E-MI-32178 |
MNDR | hsa-miR-23b-3p | Lung adenocarcinoma | MNDR-E-MI-32179 |
MNDR | hsa-miR-23b-3p | Thyroid carcinoma | MNDR-E-MI-32180 |
MNDR | hsa-miR-23b-3p | Ovarian carcinoma | MNDR-E-MI-32181 |
MNDR | hsa-miR-23b-3p | Bladder urothelial carcinoma | MNDR-E-MI-32182 |
MNDR | hsa-miR-23b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-32183 |
MNDR | hsa-miR-23b-3p | Cervical cancer | MNDR-E-MI-32184 |
MNDR | hsa-miR-23b-3p | Carcinoma renal cell | MNDR-E-MI-32185 |
MNDR | hsa-miR-23b-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-32186 |
MNDR | hsa-miR-23b-3p | Renal clear cell carcinoma | MNDR-E-MI-32187 |
MNDR | hsa-miR-23b-3p | Cholangiocarcinoma | MNDR-E-MI-32188 |
MNDR | hsa-miR-23b-3p | Esophageal cancer | MNDR-E-MI-32189 |
MNDR | hsa-miR-23b-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-32190 |
MNDR | hsa-miR-23b-3p | T acute lymphoblastic leukemia | MNDR-E-MI-32191 |
MNDR | hsa-miR-23b-3p | Acute t cell leukemia | MNDR-E-MI-32192 |
MNDR | hsa-miR-23b-3p | Fibromyalgia | MNDR-E-MI-32193 |
MNDR | hsa-miR-23b-3p | Adenoma | MNDR-E-MI-32194 |
MNDR | hsa-miR-23b-3p | Breast invasive carcinoma | MNDR-E-MI-32195 |
MNDR | hsa-miR-23b-3p | Hepatocellular carcinoma | MNDR-E-MI-32196 |
MNDR | hsa-miR-23b-3p | Familiar ovarian carcinoma | MNDR-E-MI-32197 |
MNDR | hsa-miR-23b-3p | B-cell lymphoma | MNDR-E-MI-32198 |
MNDR | hsa-miR-23b-3p | Rheumatoid arthritis | MNDR-E-MI-32199 |
MNDR | hsa-miR-23b-3p | Malignant pleural mesothelioma | MNDR-E-MI-32200 |
MNDR | hsa-miR-23b-3p | Neuroblastoma | MNDR-E-MI-32201 |
MNDR | hsa-miR-23b-3p | Hodgkin lymphoma | MNDR-E-MI-32202 |
MNDR | hsa-miR-23b-3p | Ulcerative colitis | MNDR-E-MI-32203 |
MNDR | hsa-miR-23b-3p | Neuromyelitis optica | MNDR-E-MI-32204 |
MNDR | hsa-miR-23b-3p | Acute myeloid leukemia | MNDR-E-MI-32205 |
MNDR | hsa-miR-23b-3p | Colorectal cancer | MNDR-E-MI-32206 |
MNDR | hsa-miR-23b-3p | Multiple myeloma | MNDR-E-MI-32207 |
MNDR | hsa-miR-23b-3p | Acute lymphocytic leukemia | MNDR-E-MI-32208 |
MNDR | hsa-miR-23b-3p | Uterine cervical neoplasms | MNDR-E-MI-32209 |
MNDR | hsa-miR-23b-3p | Diabetic nephropathies | MNDR-E-MI-32210 |
MNDR | hsa-miR-23b-3p | Ependymoma | MNDR-E-MI-32211 |
MNDR | hsa-miR-23b-3p | Cardiomegaly | MNDR-E-MI-32212 |
MNDR | hsa-miR-23b-3p | Nasopharyngeal cancer | MNDR-E-MI-32213 |
MNDR | hsa-miR-23b-3p | Prostatic neoplasms | MNDR-E-MI-32214 |
MNDR | hsa-miR-23b-3p | Sleep deprivation | MNDR-E-MI-32215 |
MNDR | hsa-miR-23b-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-32216 |
MNDR | hsa-miR-23b-3p | Brain injury chronic | MNDR-E-MI-32217 |
MNDR | hsa-miR-23b-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-32218 |
MNDR | hsa-miR-23b-3p | Stroke lacunar | MNDR-E-MI-32219 |
MNDR | hsa-miR-23b-3p | Low grade dysplastic nodule | MNDR-E-MI-32220 |
MNDR | hsa-miR-23b-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-32221 |
MNDR | hsa-miR-23b-3p | Tubulovillous adenoma | MNDR-E-MI-32222 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ACVR2B | Homo sapiens | RR00039546 |
TOP